Blue Sail Medical Co.,Ltd. (SHE:002382)
China flag China · Delayed Price · Currency is CNY
5.91
+0.02 (0.34%)
Sep 14, 2026, 3:04 PM CST

Blue Sail Medical Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-534.75-758.94-445.61-568.36-372.321,156
Depreciation & Amortization
573.03572.52526524.51489.01332.16
Other Amortization
16.216.0332.6150.8851.4434.54
Loss (Gain) From Sale of Assets
1.171.650.841.92-0.071.98
Asset Writedown & Restructuring Costs
189.3157.916.2921.476.942,069
Loss (Gain) From Sale of Investments
-4.39-17.311.1-83.56-252.45-1,123
Provision & Write-off of Bad Debts
16.777.8722.7418.691.9120.1
Other Operating Activities
315.86298.19235.02233.45161.99188.73
Change in Accounts Receivable
-366.4194.15-311.05-247.61413.41182.7
Change in Inventory
104.410.22-207.17-146.32176.54-426.52
Change in Accounts Payable
117.4849.14262.3199.73-165.95-220.63
Change in Other Net Operating Assets
11.379.220.4543.2419.62
Operating Cash Flow
527.47457.72135.85-72.89494.472,246
Operating Cash Flow Growth
-11.46%236.93%---77.98%-38.84%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-356.55-553.01-774.28-774.14-896.86-2,582
Sale of Property, Plant & Equipment
7.032.61.672.5610.986.37
Cash Acquisitions
-368.76-228.7671.96--53.25-
Investment in Securities
424.3-507.3950.76-130.081,01533.06
Other Investing Activities
31.1222.186.4230.9138.7449.45
Investing Cash Flow
-262.86-1,264-643.48-870.75114.82-2,493

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-1,1121,6441,040142.761,477
Total Debt Issued
1,7631,1121,6441,040142.761,477
Long-Term Debt Repaid
--1,116-1,824-393.24-793.42-1,984
Lease Payments
-7.28-18.67-15.38-19.43-16.25-17.68
Total Debt Repaid
-3,028-1,116-1,824-393.24-793.42-1,984
Net Debt Issued (Repaid)
-1,265-3.66-180.18647.08-650.66-506.26
Issuance of Common Stock
--0.02---
Repurchase of Common Stock
---30---
Common Dividends Paid
-249.07-168.38-177.44-513.78-61.02-477.2
Other Financing Activities
482.17710.361,710--0.016.45
Financing Cash Flow
-1,032538.321,323133.31-711.69-977.02

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-47.6-2.6-7.2220.5659.6348.07
Net Cash Flow
-814.52-270.93807.91-789.77-42.77-1,176

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
170.92-95.29-638.43-847.03-402.39-336.22
Free Cash Flow Growth
------
Free Cash Flow Margin
2.58%-1.66%-10.21%-17.19%-8.21%-4.15%
Free Cash Flow Per Share
0.18-0.10-0.63-0.83-0.40-0.32
Levered Free Cash Flow
2,771-64.78-1,132-994.93-866.98-48.7
Unlevered Free Cash Flow
2,986124.89-957.73-882.14-786.0534.62
Free Cash Flow After Leases
163.64-113.96-653.81-866.46-418.64-353.9

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
1.834.153.753.93--
Cash Income Tax Paid
--162.63-314.21-270.3-540.33-69.07
Change in Working Capital
-45.72179.79-253.16-271.9408.01-434.02